Immune reconstitution inflammatory syndrome (IRIS) is an aberrant inflammatory response against an underlying infection after initiation of antiretroviral therapy (ART) in HIV+ persons and is associated with significant morbidity and mortality. Inflammation and T cell activation are dependent on cell metabolism and specific metabolic pathways could regulate T cell activation. We hypothesized that differences in metabolic profile could be used as biomarkers to further elucidate pathogenesis of IRIS.
Non-targeted global metabolomic profiling was performed on plasma samples derived from a perspective longitudinal study of 30 HIV patients (17 HIV non-IRIS and 13 HIV IRIS) at pre-ART (CD4 ≤ 100 cells/mm3), 1-month post-ART, and 12-month post-ART timepoints by Metabolon, Inc. Metabolites were identified by liquid chromatography/mass spectrometry followed by comparison to a reference library. Plasma cytokines were measured using Meso Scale multiplex cytokine detection kit then correlated with metabolic pathways via Spearman correlation.
A total of 832 metabolites were identified in plasma samples. Comparing HIV IRIS and HIV non-IRIS groups, more differentially expressed metabolites reaching statistically significance ((p≤0.05) were identified at pre-ART and 1-month post-ART time points than the 12-month post-ART time point. Lipid and amino acid metabolites composed the majority of the compounds that achieved statistical significance. The IRIS group had significantly higher levels of select acylcarnitines, and lower levels of plasmalogen and phosphatidylcholine at pre-ART. Amino acids including tryptophan, glutamate, glycine, and tyrosine metabolism were found to be differentially expressed in IRIS and non-IRIS groups at pre-ART and 1-month post-ART. Spearman correlations revealed that glutamate metabolism was positively correlated with TNF, while tryptophan and glycine metabolism were negatively correlated with IL-10, and D-dimer respectively in the IRIS group at pre-ART.
HIV+ persons who develop IRIS have a distinct metabolic profile with perturbed lipid and amino acid metabolism that is associated with known inflammatory mediators of IRIS. These data suggest that evaluation of immunometabolism and its role in inflammation associated with IRIS warrants further investigation.